News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current LPGIF market cap is 0. The company's latest EPS is CAD -0.0036 and P/E is -141.67.
| Year End July 30 2022 | 2022 |
|---|---|
| CAD ($) | |
| Total Revenue | 0 |
| Operating Income | -3k |
| Net Income | -74k |
| Year End July 30 2022 | 2022 |
|---|---|
| CAD ($) | |
| Total Assets | 25k |
| Total Liabilities | 285k |
| Total Equity | -260k |
| Year End July 30 2022 | 2022 |
|---|---|
| CAD ($) | |
| Operating | -3k |
| Investing | N/A |
| Financing | 3k |
| Market Cap | 0 |
| Price to Earnings Ratio | -141.67 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | -40.5 |
| Dividend Yield | - |
| Shares Outstanding | 20.65M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | LSL Pharma Group Inc (PK) |
| Address |
3030, boul. le carrefour, bureau 1002, laval qu��bec H7T 2P5 |
| Website | https://www.lsl-pharma.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
